postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

5
Original research article Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat A.L. Mu ¨ller, C.M. Llados, H.B. Croxatto* Pontifı ´cia Universidad Cato ´lica de Chile, Facultad de Ciencias Biolo ´gicas, Unidad de Reproduccio ´n y Desarrollo, Av. Alameda Bernardo O’Higgins 340, Santiago, Chile Received 28 October 2002; received in revised form 8 January 2003; accepted 13 January 2003 Abstract Levonorgestrel (LNG), a progestin widely used for regular hormonal contraception, is also used for emergency contraception (EC) to prevent pregnancy after unprotected intercourse. However, its mode of action in EC is only partially understood. One unresolved question is whether or not EC prevents pregnancy by interfering with postfertilization events. Here, we report the effects of acute treatment with LNG upon ovulation, fertilization and implantation in the rat. LNG inhibited ovulation totally or partially, depending on the timing of treatment and/or total dose administered, whereas it had no effect on fertilization or implantation when it was administered shortly before or after mating, or before implantation. It is concluded that acute postcoital administration of LNG at doses several-fold higher than those used for EC in women, which are able to inhibit ovulation, had no postfertilization effect that impairs fertility in the rat. © 2003 Elsevier Inc. All rights reserved. Keywords: Levonorgestrel; Emergency contraception; Ovulation; Fertilization; Implantation; Rat 1. Introduction Levonorgestrel (LNG), a progestin widely used for reg- ular hormonal contraception, is also used for emergency contraception (EC), alone or combined with estrogen. Hor- monal EC is taken after unprotected intercourse in order to prevent pregnancy. The mode of action of EC has become the subject of heated debate in several Latin American and Caribbean countries. The main question is centered on whether or not EC prevents pregnancy by interfering with postfertilization events. This issue is of importance for many people, considering that a new human life begins at the time fertilization is completed. Accordingly, interfer- ence with postfertilization events would lead to loss of human life. When a woman uses EC she does not know whether she takes the pills before or after ovulation and before or after fertilization. For ethical and logistical reasons, it has not been possible to segregate groups of women who take EC after fertilization in order to assess its effect on the estab- lishment of pregnancy. Hence, there is no direct evidence, in favor or against, that acute treatment with LNG prevents pregnancy by interference with postfertilization events. On the other hand, animal experimentation allows segregating groups treated before or after critical events, such as ovu- lation, fertilization and implantation in order to define the contribution of pre- and postfertilization events to the con- traceptive efficacy of the drug. Even though extrapolation of the results to the human has considerable limitations, ex- periments in animals often shed light on possible mecha- nisms operating in the human. It is known that acute treatment with LNG administered during the follicular phase can inhibit or delay ovulation in various species, including the human [1]. Also, acute treat- ment with LNG administered within the first 10 h after intercourse decreased the number of spermatozoa recovered from the uterine cavity in women [2]. To our knowledge, no such effect has been described in animals. Furthermore, its action when given after mating is not well documented. Therefore, we undertook experiments in animals to inves- tigate the possible occurrence of postfertilization effects. In this paper, we describe the effects of acute treatment with LNG given either before or after ovulation or fertili- zation, or before implantation upon fertility parameters in the rat. The main intervention variable was the time of * Corresponding author. Tel.: 56-2-686-2878; fax: 56-2-222-5515. E-mail address: [email protected] (H.B. Croxatto). Contraception 67 (2003) 415– 419 0010-7824/03/$ – see front matter © 2003 Elsevier Inc. All rights reserved. doi:10.1016/S0010-7824(03)00021-0

Upload: al-mueller

Post on 01-Nov-2016

215 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

Original research article

Postcoital treatment with levonorgestrel does not disruptpostfertilization events in the rat

A.L. Muller, C.M. Llados, H.B. Croxatto*Pontifıcia Universidad Catolica de Chile, Facultad de Ciencias Biologicas, Unidad de Reproduccion y Desarrollo, Av. Alameda Bernardo O’Higgins

340, Santiago, Chile

Received 28 October 2002; received in revised form 8 January 2003; accepted 13 January 2003

Abstract

Levonorgestrel (LNG), a progestin widely used for regular hormonal contraception, is also used for emergency contraception (EC) toprevent pregnancy after unprotected intercourse. However, its mode of action in EC is only partially understood. One unresolved questionis whether or not EC prevents pregnancy by interfering with postfertilization events. Here, we report the effects of acute treatment with LNGupon ovulation, fertilization and implantation in the rat. LNG inhibited ovulation totally or partially, depending on the timing of treatmentand/or total dose administered, whereas it had no effect on fertilization or implantation when it was administered shortly before or aftermating, or before implantation. It is concluded that acute postcoital administration of LNG at doses several-fold higher than those used forEC in women, which are able to inhibit ovulation, had no postfertilization effect that impairs fertility in the rat. © 2003 Elsevier Inc. Allrights reserved.

Keywords: Levonorgestrel; Emergency contraception; Ovulation; Fertilization; Implantation; Rat

1. Introduction

Levonorgestrel (LNG), a progestin widely used for reg-ular hormonal contraception, is also used for emergencycontraception (EC), alone or combined with estrogen. Hor-monal EC is taken after unprotected intercourse in order toprevent pregnancy. The mode of action of EC has becomethe subject of heated debate in several Latin American andCaribbean countries. The main question is centered onwhether or not EC prevents pregnancy by interfering withpostfertilization events. This issue is of importance formany people, considering that a new human life begins atthe time fertilization is completed. Accordingly, interfer-ence with postfertilization events would lead to loss ofhuman life.

When a woman uses EC she does not know whether shetakes the pills before or after ovulation and before or afterfertilization. For ethical and logistical reasons, it has notbeen possible to segregate groups of women who take ECafter fertilization in order to assess its effect on the estab-lishment of pregnancy. Hence, there is no direct evidence, in

favor or against, that acute treatment with LNG preventspregnancy by interference with postfertilization events. Onthe other hand, animal experimentation allows segregatinggroups treated before or after critical events, such as ovu-lation, fertilization and implantation in order to define thecontribution of pre- and postfertilization events to the con-traceptive efficacy of the drug. Even though extrapolation ofthe results to the human has considerable limitations, ex-periments in animals often shed light on possible mecha-nisms operating in the human.

It is known that acute treatment with LNG administeredduring the follicular phase can inhibit or delay ovulation invarious species, including the human [1]. Also, acute treat-ment with LNG administered within the first 10 h afterintercourse decreased the number of spermatozoa recoveredfrom the uterine cavity in women [2]. To our knowledge, nosuch effect has been described in animals. Furthermore, itsaction when given after mating is not well documented.Therefore, we undertook experiments in animals to inves-tigate the possible occurrence of postfertilization effects.

In this paper, we describe the effects of acute treatmentwith LNG given either before or after ovulation or fertili-zation, or before implantation upon fertility parameters inthe rat. The main intervention variable was the time of

* Corresponding author. Tel.:�56-2-686-2878; fax:�56-2-222-5515.E-mail address: [email protected] (H.B. Croxatto).

Contraception 67 (2003) 415–419

0010-7824/03/$ – see front matter © 2003 Elsevier Inc. All rights reserved.doi:10.1016/S0010-7824(03)00021-0

Page 2: Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

administration relative to ovulation, mating and fertiliza-tion. The measured variables were percentage of animalsovulating, mean number of ovulated eggs, mean percentageof fertilized eggs and mean number of implanted embryos.

2. Material and methods

2.1. Animals

Adult Sprague Dawley female rats weighing approxi-mately 200 g and adult male rats 5–7 months old were used.All animals were kept in the same room with water and petchow ad libitum, illumination from 7:30 a.m. to 9:30 p.m.and temperature 20–24°C.

Females were submitted daily to vaginal smears. Estrouscycle stages were classified according to Turner [3]. In orderto obtain pregnant animals, each proestrous or estrous fe-male was caged individually with two intact males for 1 h orall night. At the end of this period, the presence of semen,blood or a plug in the vagina and/or the presence of sper-matozoa in the vaginal smear verified mating. If matingoccurred, the day of estrus was designated day 1 of preg-nancy (P1).

Animal care and experimental procedures were doneaccording with the ethical guidelines of the InstitutionalEthics Committee.

2.2. LNG solutions

Crystalline LNG was obtained from Norplant implants(Leiras, Turku, Finland) or from Schering AG, Berlin, Ger-many. LNG was dissolved in 100 �L ethanol (Merck,Darmstadt, Germany) and was further diluted with 1,2-propanediol (Sigma, St. Louis, MO, USA) to a final con-centration of 100 �g/mL.

2.3. Treatments

Each rat was injected subcutaneously with LNG 50�g/kg body weight per injection or with vehicle, except inone control group that was left undisturbed. This dose isapproximately four times higher than the dose used for ECand its bioavailability is presumed to be higher due tosystemic administration. This dose was given one to fourtimes with 12-h intervals. The timing of treatment relative toovulation, mating, fertilization and implantation is summa-rized in Figs. 1 and 2.

2.4. Effect of preovulatory treatment upon ovulation

Each rat was injected with LNG or vehicle twice per day(8:00 a.m. and 8:00 p.m.) at both diestrus and proestrus[Group 1 (G1)] or with a single injection at 8:00 p.m. ofdiestrus (G2) or at 8:00 a.m. of proestrus (G3). These ratswere killed at estrus in order to assess percentage of animalsovulating and mean number of ovulated eggs per ovulatingrat.

2.5. Effect of treatment before mating and ovulation uponfertilization and implantation

The results of the previous experiment indicated that asingle injection of LNG in proestrus was unlikely to affectovulation. Therefore, it was feasible to study effects ofpreovulatory treatment upon fertilization and implantation.

Proestrous rats were injected with LNG or vehicle onceat 4:00 p.m. Each rat was caged with two males from 9:30to 10:30 p.m. If mating was verified, the female was isolatedand killed on P2 in order to assess the percentage of fertil-ized eggs (G4). If mating had not taken place by 10:30 p.m.,the female remained overnight with the males. When mat-ing was verified the following morning, the female wasisolated and killed on P2 in order to assess the percentage of

Fig. 1. Effects of preovulatory administration of levonorgestrel (LNG) or vehicle upon ovulation in the rat. � timing of each injection of LNG or vehicle;� � the approximate time of ovulation; ● � autopsy. The time scale indicates days of the estrous cycle, with light and dark periods depicted by horizontalwhite and black bars, respectively. n � number of animals treated. †Per ovulating rat; *p � 0.02.

416 A.L. Muller et al. / Contraception 67 (2003) 415–419

Page 3: Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

fertilized eggs or killed on P12 to assess the number ofimplanted embryos (G5). Failure to mate was infrequent andfemales that failed to mate were discarded.

2.6. Effect of treatment after mating and before ovulationupon fertilization and implantation

Proestrous rats were caged with males from 9:00 to10:00 p.m. Those that mated were injected with LNG at11:00 p.m. (G6) or with LNG or vehicle at 11:00 p.m. andagain 12 h later (G7). These rats were killed on P2 or P12.

2.7. Effect of treatment after ovulation and before matingupon fertilization and implantation

Females were injected with LNG or vehicle once at 8:00a.m. on the day of estrus and immediately caged with malesuntil 9:00 a.m. (G8). Those that mated were isolated andkilled on P2 or P12.

2.8. Effect of treatment after ovulation and mating uponfertilization and implantation

Females were caged with males from 8:00 to 9:00 a.m.on the day of estrus. If mating was verified, the female wasinjected immediately with LNG or vehicle and killed on P2or P12 (G9).

2.9. Effect of treatment after fertilization uponimplantation

Proestrous rats were caged with males overnight. Matedfemales were injected twice with LNG or vehicle at 11:00

p.m. of P1 and at 11:00 a.m. of P2 (G10) or at 11:00 p.m.of P3 and at 11:00 a.m. of P4 (G11) and killed on P12. Aseparate assessment (not shown) determined that after mat-ing occurring overnight, fertilization was completed bymidmorning in our rat colony. Thus, both of these treat-ments were given after fertilization had taken place.

2.10. Assessment of ovulation, fertilization andimplantation

Unmated rats were killed by an overdose of ether at noonof estrus to assess the number of oocytes present in theiroviducts. Mated rats were killed between 3:00 and 4:00 p.m.on P2 or P12 to assess the number of fertilized and unfer-tilized eggs and the number of implanted embryos, respec-tively. At estrus or P2, oviducts were removed and flushedwith saline to count the number of eggs using low magni-fication (250�). When necessary, cumulus-egg complexeswere dispersed with hyaluronidase (Sigma). In order toassess the occurrence of fertilization, eggs were placedbetween slide and cover slip, and were examined usingbright field microscopy (400�). Eggs were considered fer-tilized when a sperm tail was seen in the cytoplasm or in theperivitelline space. At P12, each implantation site was dis-sected, using a stereomicroscope, to verify the presence orabsence of an embryo (60�). Only implantation sites con-taining live embryos are presented in the results.

2.11. Data analysis

Ovulation data are expressed as percentage of rats thatovulated calculated over the total number of animals treated

Fig. 2. Effects of levonorgestrel (LNG) or vehicle upon fertilization and implantation in the rat. � timing of each injection of LNG or vehicle; — � periodof pairing resulting in mating; A, B, and C � approximate times of ovulation, fertilization and implantation, respectively; ● � autopsy. The time scaleindicates days of the estrous cycle (Pro: proestrus; Est: estrus) and days of pregnancy (P1–12). n � number of animals treated. *Animals not injected withvehicle. None of the differences was statistically significant.

417A.L. Muller et al. / Contraception 67 (2003) 415–419

Page 4: Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

and also as mean number of ovulated oocytes per ovulatingrat � SE. All rats that mated had either fertilized eggs orimplanted embryos. Thus, only the mean percentage offertilized eggs and the mean number implanted embryos ispresented per group. One-sided Fisher’s exact test or chi-square, as appropriate, was applied to two-way tables ofpercentage of rats that ovulated. Kruskal–Wallis test wasused for mean number of ovulated oocytes or mean numberof implanted embryos. Differences were considered statis-tically significant at p � 0.05. All statistical analyses werecarried out on Intercooled Stata 6.0 computational programfor Windows (Stata Corporation, College Station, TX,USA).

3. Results

3.1. Effect of preovulatory treatment upon ovulation (G1,G2 and G3)

Following injection of LNG or vehicle twice per day atboth diestrus and proestrus (G1), the percentage of ovulat-ing rats was 0% and 83%, respectively. The mean numberof ovulated eggs in the control group was 8.0 � 1.6 (Fig. 1).The percentage of ovulating rats among those treated oncein the evening of diestrus (G2) or in the morning ofproestrus (G3) was 25% and 63%, respectively, with LNG,and 88% in both control groups. The difference betweenexperimental and control in G2 is statistically significant (p� 0.02). The mean number of ovulated eggs was 6.0 � 3.0and 9.0 � 2.0, respectively, for rats treated with LNG and4.7 � 0.8 and 7.1 � 0.8 for controls. These differences werenot statistically significant.

3.2. Effect of treatment before mating and ovulation uponfertilization and implantation (G4 and G5)

All rats in these experiments had either fertilized eggs onP2 or implanted embryos on P12. The mean percentage offertilized eggs after injecting LNG or vehicle at 4:00 p.m. ofproestrus and mating between 9:30 and 10:30 p.m. (G4),was 100% in both groups. Among those mated overnight(G5), the mean percentage of fertilized eggs was 100% inthe LNG group and 98 � 1.8% in the controls, and the meannumber of implanted embryos was 9.2 � 1.1 and 10.2 �0.5, respectively (Fig. 2). None of these differences wasstatistically significant.

3.3. Effect of treatment after mating and before ovulationupon fertilization and implantation (G6 and G7)

All rats had either fertilized eggs on P2 or implantedembryos on P12. The mean percentage of fertilized eggs inproestrous rats mated between 9:00 and 10:00 p.m. andinjected with LNG at 11:00 p.m. (G6) was 100% and themean number of implanted embryos was 11.2 � 0.4. The

number of implanted embryos in contemporaneous undis-turbed animals (not injected) was 11.0 � 0.5 (indicated byasterisk in Fig. 2). In those injected with LNG at 11:00 p.m.of proestrus and 11:00 a.m. of estrus (G7), the mean per-centage of fertilized eggs was 94 � 5.6% and the meannumber of implanted embryos was 10.8 � 0.5 for LNG and10.0 � 0.7 for controls (Fig. 2). None of these differenceswas statistically significant.

3.4. Effect of treatment after ovulation and before matingupon fertilization and implantation (G8)

The mean percentage of fertilized eggs in rats treated at8:00 a.m. of estrus and mated within the next hour was 75� 14.8% for LNG and 97 � 3.3% for controls. The meannumber of implanted embryos was 15.3 � 0.6 and 12.9 �0.8, respectively (Fig. 2). None of these differences wasstatistically significant.

3.5. Effect of treatment after ovulation and mating uponfertilization and implantation (G9)

The mean percentage of fertilized eggs in rats injectedimmediately after mating in early estrus was 97 � 3.3% forLNG and 100% for vehicle, and the mean number of im-planted embryos was 11.8 � 1.6 for LNG and 12.8 � 0.8for controls (Fig. 2). None of these differences was statis-tically significant.

3.6. Effect of treatment after fertilization uponimplantation (G10 and G11)

All rats had implanted embryos on P12. The mean num-ber of implanted embryos in those treated at 11:00 p.m. ofP1 and at 11:00 a.m. of P2 (G10) was 11.0 � 0.8 for LNGand 10.6 � 0.7 for controls. In those injected with LNG orvehicle at 11:00 p.m. of P3 and at 11:00 a.m. of P4 (G11),the mean number of implanted embryos was 11.8 � 0.8 and10.0 � 0.9, respectively (Fig. 2). None of the differenceswas statistically significant.

4. Discussion

The results presented show that acute treatment withLNG, either shortly before or after mating, before or afterfertilization, or before implantation, have no effect on theestablishment of pregnancy in the intact rat (Fig. 2). Thisexcludes that LNG interferes with postfertilization steps inthis species and is in keeping with the fact that daily treat-ment of castrated rats with LNG is able to sustain pregnancy[4]. No evidence of antifertility effect attributable to inter-ference with postfertilization events could be demonstrated.In contrast, preovulatory treatment with LNG was able toinhibit ovulation. The suppression of ovulation was heavilydependent upon the schedule of administration (Fig. 1).

418 A.L. Muller et al. / Contraception 67 (2003) 415–419

Page 5: Postcoital treatment with levonorgestrel does not disrupt postfertilization events in the rat

Following injection of LNG either twice per day, once in theevening of diestrus or once in the morning of proestrus, thepercentage of animals that failed to ovulate was 100%, 75%and 37%, respectively. The effectiveness of a single injec-tion diminished as treatment became closer to the expectedtime of the ovulatory episode. Therefore, LNG inhibitedovulation totally or partially depending on the timing oftreatment and possibly the total dose administered. Thedose–effect relationship was not adequately examined. Thepossibility that ovulation may have been delayed cannot beexcluded, since we did not perform autopsies on the thirdday after estrus to test for the occurrence of delayed ovu-lation.

Inhibition of ovulation in the rat after single adminis-tration of LNG has been documented previously. Ovula-tion was delayed in rats injected in the afternoon ofmetaestrus with LNG 50 �g/kg dissolved in oil, whereasit was totally suppressed by 200 �g/kg [5]. When LNGdissolved in oil was injected in the afternoon of diestrus,it blocked ovulation in a dose-dependent fashion; theantiovulatory dose was 200 –400 �g/kg [6]. The mostobvious differences with our experiments are the vehicleused and the time of administration. In our study, 50�g/kg of LNG dissolved in 1,2-propanediol injected inthe evening of diestrus inhibited ovulation in 75% of theanimals and four doses administered 12 h apart beginningin the morning of diestrus (in total � 200 �g/kg), com-pletely suppressed ovulation.

There is much information on the effects of LNG uponovulation in women. In brief, LNG can inhibit ovulationwhen it is administered one or more days before follicularrupture [7–9]. It is known that LNG affects ovulation inanimals [5,10] and women [11], at least through interfer-ence with signaling from the pituitary. Inconsistent effectsof LNG upon endometrial markers of receptivity have beenreported in women [8,9]. The effect of LNG upon markersof receptivity in the rat was not addressed in the presentstudy.

In conclusion, postcoital administration of LNG at doses

able to affect ovulation had no antifertility effect attribut-able to interference with postfertilization events in the rat.

Acknowledgments

Support for this study was provided by Fundacion Insti-tuto Milenio de Investigacion en Biologıa Fundamental yAplicada, Catedra Presidencial en Ciencias, Fondecyt#898000-8 and RF98024#98.

References

[1] Croxatto HB, Devoto L, Durand M, et al. Mechanism of action ofhormonal preparations used for emergency contraception: a review ofthe literature. Contraception 2001;63:111–21.

[2] Kesseru E, Garmendia F, Westphal N, Parada J. The hormonal andperipheral effects of d-norgestrel in postcoital contraception. Contra-ception 1974;10:411–24.

[3] Turner CD, editor. General endocrinology. Philadelphia: WB Saun-ders, 1960.

[4] Kuhnz W, Beier S. Comparative progestational and androgenic ac-tivity of norgestimate and levonorgestrel in the rat. Contraception1994;49:275–89.

[5] Beattie CW, Corbin A. The differential effects of diestrous proges-togen administration on proestrous gonadotrophin levels. Endocrinol-ogy 1975;97:885–90.

[6] Upton GV, Corbin A. The relevance of the pharmacological proper-ties of a progestational agent to its clinical effects as a combinationoral contraceptive. Yale J Biol Med 1989;62:445–57.

[7] Hapangama D, Glasier AF, Baird DT. The effects of peri-ovulatoryadministration of levonorgestrel on the menstrual cycle. Contracep-tion 2001;63:123–9.

[8] Durand M, Cravioto M, Raymond EG, et al. On the mechanism ofaction of short-term levonorgestrel administration in emergency con-traception. Contraception 2001;64:227–34.

[9] Marions L, Hultenby K, Lindell I, et al. Emergency contraceptionwith mifepristone and levonorgestrel: mechanism of action. ObstetGynecol 2002;100:65–71.

[10] Spona J, Schneider WHF, Bieglmayer C, Schroeder R, Pirker R.Ovulation inhibition with different doses of levonorgestrel and otherprogestogens: clinical and experimental investigations. Acta ObstetGynecol Scand 1979;88(Suppl):7–15.

[11] Croxatto HB. Mechanisms that explain the contraceptive action ofprogestin implants for women. Contraception 2002;65:21–7.

419A.L. Muller et al. / Contraception 67 (2003) 415–419